Jim leads all day to day operations for Nanocopoeia’s business, technology and portfolio development. Jim brings more than 30 years of global Brand and generic pharmaceutical manufacturing, product commercialization, engineering and operational excellence expertise. Prior to joining Nanocopoeia as Chief Operating Officer, Jim successfully led multiple operational/ business turn-arounds in both Brand and generic businesses serving in senior and executive leadership roles for companies such as; Teva Pharmaceuticals, Actavis/Watson, Perrigo, Paddock Labs, Par Pharmaceuticals, Andrx Pharmaceuticals, Pfizer and Parke-Davis(Warner-Lambert).
Jim has been recognized for business leadership and innovative technical and operational contribution to some of the pharmaceutical industries largest global products and has established a successful track record of business performance, growth and profitability. Jim is a Summa Cum Laude graduate, Electrical Engineering, from Rochester Institute of Technology with a Masters in Technology Management from New Jersey Institute of Technology.